Cancer Electrolyte Emergencies: Mechanism and Urgency

Clinical Mastery · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

The diagnosis should follow this patient's physiology. Cancer type alone does not establish SIADH, hypercalcemia mechanism, or a specific tubular lesion.

Cancer-related electrolyte changes have several origins. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

Cancer-related electrolyte changes have several origins. Tumor biology — Cell breakdown or hormone effects; Treatment effects — Tubular injury or altered signaling; Intake and GI losses — Nutrition and vomiting / diarrhea; Kidney handling — Excretion, loss or retention. Identify the urgent abnormality, then localize its mechanism; cancer is not one electrolyte diagnosis. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

Cancer creates several pathways

Tumor hormones, cell breakdown, obstruction, poor intake, gastrointestinal losses, and treatment toxicity can produce different electrolyte disorders.

Recognize organ-threatening effects

Arrhythmia, seizures, encephalopathy, weakness, and rapidly changing kidney function require urgent assessment while the cause is investigated.

Use the pattern to choose the workup

Low sodium requires tonicity, urine studies, medication review, and exclusion of adrenal insufficiency before SIADH attribution. High calcium requires PTH-guided evaluation. Rising potassium/phosphate with falling calcium and AKI raises tumor-lysis concern. Low magnesium after platinum exposure suggests a different tubular problem.

Do not substitute the cancer name for a diagnosis

Small-cell lung cancer does not prove SIADH, and a bone lesion does not establish every cause of hypercalcemia. Stabilize the dangerous disturbance, then treat the mechanism supported by this patient’s tests. Monitor for treatment-induced shifts in the other electrolytes and changing renal clearance.

Expect interacting abnormalities

Treating one ion can alter another. Follow acid–base status, renal clearance, volume tolerance, and the effects of repeated replacement.

Avoid assumed frequency claims

The diagnosis should follow this patient's physiology. Cancer type alone does not establish SIADH, hypercalcemia mechanism, or a specific tubular lesion.

Continue learning